Search research articles
Contact Us
Filters
Showing results (461-470 of 519) with videos related to
Page
of 52
Sort By:
Advances in Radiation Oncology
|
December 6, 2017
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
R Charles Nichols, Chen Hu, Jean-Paul Bahary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2008
Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients
Laura M Kenny, R Charles Coombes, Inger Oulie, et al.
Scientific Reports
|
March 14, 2020
A novel hotspot specific isothermal amplification method for detection of the common PIK3CA p.H1047R breast cancer mutation
Melpomeni Kalofonou, Kenny Malpartida-Cardenas, George Alexandrou, et al.
Scientific Reports
|
April 15, 2025
Permeability scaling relationships of volcanic tuff from core to field scale measurements
Dolan D Lucero, S Michelle Bourret, John P Ortiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2005
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide
Claudio Praga, Jonas Bergh, Judith Bliss, et al.
Oncogene
|
October 31, 2012
The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
L J Monteiro, P Khongkow, M Kongsema, et al.
International Journal of Oncology
|
June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
Richard E Francis, Stephen S Myatt, Janna Krol, et al.
Nucleic Acids Research
|
April 13, 2013
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
Loredana Pellegrino, Justin Stebbing, Vania M Braga, et al.
Nucleic Acids Research
|
October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
Manikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Molecular Cancer Therapeutics
|
March 17, 2018
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
Hetal Patel, Manikandan Periyasamy, Georgina P Sava, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 519) with videos related to
Sort By:
Page
of 52
Advances in Radiation Oncology
|
December 6, 2017
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
R Charles Nichols, Chen Hu, Jean-Paul Bahary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2008
Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients
Laura M Kenny, R Charles Coombes, Inger Oulie, et al.
Scientific Reports
|
March 14, 2020
A novel hotspot specific isothermal amplification method for detection of the common PIK3CA p.H1047R breast cancer mutation
Melpomeni Kalofonou, Kenny Malpartida-Cardenas, George Alexandrou, et al.
Scientific Reports
|
April 15, 2025
Permeability scaling relationships of volcanic tuff from core to field scale measurements
Dolan D Lucero, S Michelle Bourret, John P Ortiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2005
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide
Claudio Praga, Jonas Bergh, Judith Bliss, et al.
Oncogene
|
October 31, 2012
The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
L J Monteiro, P Khongkow, M Kongsema, et al.
International Journal of Oncology
|
June 11, 2009
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
Richard E Francis, Stephen S Myatt, Janna Krol, et al.
Nucleic Acids Research
|
April 13, 2013
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
Loredana Pellegrino, Justin Stebbing, Vania M Braga, et al.
Nucleic Acids Research
|
October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
Manikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Molecular Cancer Therapeutics
|
March 17, 2018
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
Hetal Patel, Manikandan Periyasamy, Georgina P Sava, et al.
Page
of 52